Cialis DP Dragon Pharma — Overview
Cialis DP Dragon Pharma contains tadalafil at 20 mg per tablet — the longest-acting oral PDE5 inhibitor available, with a duration of action of up to 36 hours per dose. Unlike shorter-acting agents that require precise timing, tadalafil's extended half-life allows a single dose to cover an entire weekend window, and at low daily doses (5 mg/day) it provides continuous erectile function support without any on-demand timing requirement.
For athletes on AAS cycles, sexual dysfunction is a predictable consequence of hormonal suppression. Tadalafil is the standard pharmaceutical solution for on-cycle ED — it works independently of testosterone levels by directly addressing the vascular mechanism of erection. This page covers tadalafil's mechanism, its on-demand and daily dosing options, how it differs from shorter-acting PDE5 inhibitors, and the drug interactions and blood pressure considerations relevant to AAS users.
Tadalafil PDE5 Inhibitor 36-Hour Duration On-Demand or Daily Food-Independent On-Cycle Compatible
About the Compound: Tadalafil
Tadalafil is a selective inhibitor of phosphodiesterase type 5 (PDE5) — the enzyme responsible for breaking down cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Sexual stimulation triggers the release of nitric oxide (NO) from nerve endings and endothelial cells in penile tissue, which stimulates guanylate cyclase to produce cGMP. Elevated cGMP causes smooth muscle relaxation in the corpus cavernosum, allowing arterial blood to flow in and produce an erection. PDE5 normally terminates this process by degrading cGMP; tadalafil blocks PDE5 and prolongs cGMP activity, sustaining the vasodilatory and erectile response to stimulation.
Tadalafil does not produce erections in the absence of sexual stimulation — it requires the nitric oxide signal to initiate the cGMP pathway. It differs from sildenafil and vardenafil primarily in its pharmacokinetics: a half-life of approximately 17.5 hours gives tadalafil its characteristic 36-hour window of responsiveness from a single dose, and its absorption is not affected by food or alcohol, making timing logistics simpler than for shorter-acting agents.
Active Substance
Tadalafil
Strength per Tablet
20 mg
Mechanism
Selective PDE5 inhibitor
What Tadalafil Does
Tadalafil's primary effect is reliable erectile response to sexual stimulation within a wide time window. Its secondary effects are relevant to athletes and cycle users:
- Erectile function restoration — by preventing cGMP breakdown in penile smooth muscle, tadalafil restores the ability to achieve and maintain an erection regardless of the hormonal suppression caused by exogenous AAS; it does not depend on testosterone levels to function and works at any point in the hormonal suppression phase of a cycle
- 36-hour dosing window — a single 10–20 mg dose taken on a Friday evening remains active through the weekend; the long half-life eliminates the timing anxiety associated with shorter-acting agents that have a 30-minute-to-4-hour effective window
- Daily low-dose protocol — at 5 mg/day (half a 10 mg tablet or a quarter of the 20 mg tablet), tadalafil maintains steady-state plasma concentrations that provide continuous erectile support; this eliminates on-demand dosing entirely and is commonly preferred during long cycles where ongoing sexual dysfunction management is needed
- Vasodilation and training pump — PDE5 is expressed in vascular smooth muscle throughout the body; tadalafil produces mild systemic vasodilation that athletes report as enhanced muscle pump and vascularity during training; this is a secondary, non-primary effect but is consistently noted in practical use
- Pulmonary vasodilation — PDE5 inhibition in the pulmonary vasculature reduces pulmonary artery pressure; this is the basis for tadalafil's clinical use in pulmonary arterial hypertension and may be relevant for athletes who develop elevated pulmonary pressures from heavy AAS use
On-demand vs daily dosing: for athletes who need consistent coverage through a cycle, the daily 5 mg protocol (splitting 20 mg tablets into quarters) is more practical than on-demand 20 mg dosing. Daily use produces steadier plasma levels and avoids the variability of episodic dosing. On-demand 10–20 mg is appropriate for users who only need occasional support or who prefer to minimize total drug exposure.
Who It's For
- Athletes experiencing on-cycle sexual dysfunction — the most common application; AAS use suppresses LH and FSH, reducing endogenous testosterone to near-zero; libido and erectile function follow; tadalafil bypasses the hormonal mechanism entirely and addresses the vascular component directly
- Users who want timing flexibility — the 36-hour window makes tadalafil suitable for situations where the exact timing of sexual activity is not predictable; unlike sildenafil which requires dosing 30–60 minutes before and is most effective within a 2–4 hour window, tadalafil can be taken well in advance
- Users on daily low-dose protocols — athletes who want continuous erectile function support without managing on-demand doses; the daily 5 mg approach mirrors how tadalafil is prescribed for benign prostatic hyperplasia and chronic ED and is well-tolerated for extended use
- Athletes with mild training-related blood pressure elevation — tadalafil's vasodilatory effect produces modest blood pressure reduction which can partially offset cycle-related BP elevation; not a substitute for dedicated antihypertensive management but a relevant consideration
Context & Related Products
The other oral PDE5 inhibitors available, and how tadalafil compares to each:
| Product |
Active / Duration |
Key Difference vs Tadalafil |
| Cialis DP (this product) |
Tadalafil 20 mg / up to 36 hours |
Longest-acting PDE5 inhibitor; food-independent; available as daily low-dose protocol; single dose covers weekend window |
| Viagra DP |
Sildenafil / 4–6 hours |
Shorter-acting; requires dosing 30–60 minutes before activity and within approximately 4 hours; absorption reduced by high-fat meals; preferred by users who want a clean on/off effect rather than 36-hour coverage; first-to-market and most widely recognized |
| Levitra 20 mg |
Vardenafil 20 mg / 4–5 hours |
Duration similar to sildenafil; slightly faster onset in some users; some data suggesting better efficacy in diabetic-related ED; same food interaction caution as sildenafil; comparable timing requirements to Viagra DP |
Side Effects & Management
Tadalafil's side effect profile is a direct extension of its mechanism: PDE5 inhibition produces systemic vasodilation, and the side effects reflect vascular effects in tissues beyond the target. Most are mild and dose-dependent.
| What May Occur |
Background |
How to Handle It |
| Headache |
Most common reported side effect; caused by cerebral vasodilation from PDE5 inhibition in cranial blood vessels; dose-dependent and more common at 20 mg than at 5–10 mg |
Start at 10 mg to assess tolerability before using 20 mg; for daily dosing at 5 mg, headache is significantly less common; standard analgesics (ibuprofen, acetaminophen) manage breakthrough headache |
| Facial flushing |
Vasodilation in facial and neck vessels; temporary redness and warmth; more pronounced with 20 mg; typically peaks 1–2 hours after dosing and resolves within a few hours |
Reduce to 10 mg if flushing is bothersome; the effect diminishes with repeated use as tolerance to vasodilatory response develops; less common with daily 5 mg protocol |
| Muscle aches and back pain |
Unique to tadalafil among PDE5 inhibitors; attributed to inhibition of PDE11, which is expressed in skeletal muscle; typically appears 12–24 hours after the dose (corresponding to the prolonged half-life) and resolves within 48 hours |
Usually self-limiting; NSAIDs or acetaminophen for management; if persistent, switch to 10 mg; back pain and myalgia are significantly less common at the 5 mg daily dose than at 20 mg on-demand |
| Blood pressure drop (with nitrates or antihypertensives) |
PDE5 inhibitors potentiate the hypotensive effect of nitrates — the combination is contraindicated and can cause severe hypotension; additive blood pressure lowering also occurs with alpha-blockers and other antihypertensives; relevant for athletes managing cycle-induced hypertension with medications |
Do not combine with any nitrate compound (including poppers/amyl nitrite); inform any prescriber about tadalafil use when starting antihypertensives; monitor blood pressure when adding tadalafil to an existing BP management protocol |
| Nasal congestion |
Vasodilation in nasal mucosa; mild and transient; more common at higher doses |
No intervention typically needed; resolves as the dose clears; decongestants can provide relief if symptomatic |
References
| Source |
Topic |
Link |
| NCBI Bookshelf / StatPearls |
Tadalafil pharmacology — PDE5 inhibition mechanism, clinical indications, dosing, pharmacokinetics, contraindications, and safety profile |
StatPearls: Tadalafil ↗ |
| PubMed / Eur Urol |
PDE5 inhibitors in erectile dysfunction — comparative effectiveness, safety, tolerability, and relative performance of tadalafil, sildenafil, vardenafil, and other oral PDE5 inhibitors |
Yuan et al., 2013 ↗ |
| PubMed / Expert Opin Pharmacother |
PDE5 inhibitor duration comparison — sildenafil, vardenafil, and tadalafil clinical trial comparison, with tadalafil noted for longer duration of action |
Doggrell, 2005 ↗ |
